Medinotec (MDNC) EPS (Weighted Average and Diluted) (2024 - 2025)

Medinotec (MDNC) reported EPS (Weighted Average and Diluted) of $0.03 for Q3 2025, up 50.0% on a YoY basis from $0.02 in Q3 2024, and up 200.0% quarter-over-quarter from $0.01 in Q2 2025.

Medinotec (MDNC) EPS (Weighted Average and Diluted) (2024 - 2025) Analysis & Trends

Medinotec has reported EPS (Weighted Average and Diluted) for 2 years, with the latest figure at $0.03 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.61
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 1.93
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.89
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 0.51
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.85
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 2.24
10 Medinotec - - 854,557.00 -

Historic Data

Download Data
DateValue
Aug 31, 2025 0.03
May 31, 2025 0.01
Aug 31, 2024 0.02
May 31, 2024 0.01